Francesco Mattia Mancuso

Francesco Mattia Mancuso

Scientific Innovation and Integration, Universal Diagnstics SL, Seville, Spain
+1
orcid
Senior Bioinformatician | Translational Oncology & Multi-Omi...

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2018 in Annals of Oncology
Verified
Journal Article
Open access
PDF file
CCC. Cruz
C. Cruz
MCM. Castroviejo-Bermejo
M. Castroviejo-Bermejo
Sara Gutiérrez-EnríquezSara Gutiérrez-Enríquez
Sara Gutiérrez-Enríquez
ALA. Llop-Guevara
A. Llop-Guevara
YIY.H. Ibrahim
Y.H. Ibrahim
VSV. Serra
V. Serra
BRCA1 and BRCA2 (BRCA1/2)-deficient tumors display impaired homologous recombination repair (HRR) and enhanced sensitivity to DNA damaging agents or to poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi). Their efficacy in germline BRCA1/2 (gBRCA1/2)-mutated metastatic breast cancers has been recently confirmed in clinical trials. Numerous mechanisms of PARPi resistance have been described, whose clinical relevance in gBRCA-mutated breast cancer is unknown. This highlights the need to identify functional biomarkers to better predict PARPi sensitivity. We investigated the in vivo mechanisms of PARPi resistance in gBRCA1 patient-derived tumor xenografts (PDXs) exhibiting differential response to PARPi. Analysis included exome sequencing and immunostaining of DNA damage response proteins to functionally evaluate HRR. Findings were validated in a retrospective sample set from gBRCA1/2-cancer patients treated with PARPi. RAD51 nuclear foci, a surrogate marker of HRR functionality, were the only common feature in PDX and patient samples with primary or acquired PARPi resistance. Consistently, low RAD51 was associated with objective response to PARPi. Evaluation of the RAD51 biomarker in untreated tumors was feasible due to endogenous DNA damage. In PARPi-resistant gBRCA1 PDXs, genetic analysis found no in-frame secondary mutations, but BRCA1 hypomorphic proteins in 60% of the models, TP53BP1-loss in 20% and RAD51-amplification in one sample, none mutually exclusive. Conversely, one of three PARPi-resistant gBRCA2 tumors displayed BRCA2 restoration by exome sequencing. In PDXs, PARPi resistance could be reverted upon combination of a PARPi with an ataxia-telangiectasia mutated (ATM) inhibitor. Detection of RAD51 foci in gBRCA tumors correlates with PARPi resistance regardless of the underlying mechanism restoring HRR function. This is a promising biomarker to be used in the clinic to better select patients for PARPi therapy. Our study also supports the clinical development of PARPi combinations such as those with ATM inhibitors.

28 June 2011 in PLOS Biology
Verified
Journal Article
Open access
PDF file
BCBarbara Celona
Barbara Celona
AWAssaf Weiner
Assaf Weiner
FFFrancesca Di Felice
Francesca Di Felice
Francesco Mattia MancusoFrancesco Mattia Mancuso
Francesco Mattia Mancuso
ECElisa Cesarini
Elisa Cesarini
AAAlessandra Agresti
Alessandra Agresti
The basic unit of genome packaging is the nucleosome, and nucleosomes have long been proposed to restrict DNA accessibility both to damage and to transcription. Nucleosome number in cells was considered fixed, but recently aging yeast and mammalian cells were shown to contain fewer nucleosomes. We show here that mammalian cells lacking High Mobility Group Box 1 protein (HMGB1) contain a reduced amount of core, linker, and variant histones, and a correspondingly reduced number of nucleosomes, possibly because HMGB1 facilitates nucleosome assembly. Yeast nhp6 mutants lacking Nhp6a and -b proteins, which are related to HMGB1, also have a reduced amount of histones and fewer nucleosomes. Nucleosome limitation in both mammalian and yeast cells increases the sensitivity of DNA to damage, increases transcription globally, and affects the relative expression of about 10% of genes. In yeast nhp6 cells the loss of more than one nucleosome in four does not affect the location of nucleosomes and their spacing, but nucleosomal occupancy. The decrease in nucleosomal occupancy is non-uniform and can be modelled assuming that different nucleosomal sites compete for available histones. Sites with a high propensity to occupation are almost always packaged into nucleosomes both in wild type and nucleosome-depleted cells; nucleosomes on sites with low propensity to occupation are disproportionately lost in nucleosome-depleted cells. We suggest that variation in nucleosome number, by affecting nucleosomal occupancy both genomewide and gene-specifically, constitutes a novel layer of epigenetic regulation. The accurate preservation and correct retrieval of genetic information is crucial for all living organisms. In eukaryotes, whether single-celled yeast or complex mammals, the DNA containing the genetic information is wrapped around beads of histone proteins to form structures called nucleosomes along the length of the DNA; this packaging arrangement helps protect the genome from damage and may restrict access to the genetic information. Until recently, the amount of histones and, consequently, the number of nucleosomes in the cell were considered fixed. Here, we show that in both mammalian and yeast cells that lack a single protein—HMGB1 in mammals or Nhp6a/b in yeast—the abundance of histones and nucleosomes decreases by 20%–30%. Contrary to expectations, we found that in yeast the nucleosomes do not redistribute along DNA when they are fewer: they largely maintain their positions, but the amount of time each specific DNA site spends wrapped in a nucleosome (i.e., its occupancy) decreases. Sequences that are already less frequently occupied than others in normal yeast cells lose disproportionally more nucleosomes in the mutant yeast that lack Nhp6a/b. This gives rise to a global increase in transcription and specific alterations in the expression of certain genes. This study thus contributes to a deeper understanding of how the DNA is packaged and organized. It also suggests that the cell's histone content might contribute in an important way to gene regulation.

16 November 2015 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
AGAlexandra Grippa
Alexandra Grippa
LBLaura Buxó
Laura Buxó
GMGabriel Mora
Gabriel Mora
CFCharlotta Funaya
Charlotta Funaya
FIFatima-Zahra Idrissi
Fatima-Zahra Idrissi
PCPedro Carvalho
Pedro Carvalho
Lipid droplets (LDs) are storage organelles consisting of a neutral lipid core surrounded by a phospholipid monolayer and a set of LD-specific proteins. Most LD components are synthesized in the endoplasmic reticulum (ER), an organelle that is often physically connected with LDs. How LD identity is established while maintaining biochemical and physical connections with the ER is not known. Here, we show that the yeast seipin Fld1, in complex with the ER membrane protein Ldb16, prevents equilibration of ER and LD surface components by stabilizing the contact sites between the two organelles. In the absence of the Fld1/Ldb16 complex, assembly of LDs results in phospholipid packing defects leading to aberrant distribution of lipid-binding proteins and abnormal LDs. We propose that the Fld1/Ldb16 complex facilitates the establishment of LD identity by acting as a diffusion barrier at the ER–LD contact sites.

10 November 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
MMMarija Mihailovich
Marija Mihailovich
MBMichael Bremang
Michael Bremang
VSValeria Spadotto
Valeria Spadotto
DMDaniele Musiani
Daniele Musiani
EVElena Vitale
Elena Vitale
Tiziana BonaldiTiziana Bonaldi
Tiziana Bonaldi
The synergism between c-MYC and miR-17-19b, a truncated version of the miR-17-92 cluster, is well-documented during tumor initiation. However, little is known about miR-17-19b function in established cancers. Here we investigate the role of miR-17-19b in c-MYC-driven lymphomas by integrating SILAC-based quantitative proteomics, transcriptomics and 3′ untranslated region (UTR) analysis upon miR-17-19b overexpression. We identify over one hundred miR-17-19b targets, of which 40% are co-regulated by c-MYC. Downregulation of a new miR-17/20 target, checkpoint kinase 2 (Chek2), increases the recruitment of HuR to c-MYC transcripts, resulting in the inhibition of c-MYC translation and thus interfering with in vivo tumor growth. Hence, in established lymphomas, miR-17-19b fine-tunes c-MYC activity through a tight control of its function and expression, ultimately ensuring cancer cell homeostasis. Our data highlight the plasticity of miRNA function, reflecting changes in the mRNA landscape and 3′ UTR shortening at different stages of tumorigenesis.

15 November 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
EIEsther Imperlini
Esther Imperlini
MGMassimiliano Gnecchi
Massimiliano Gnecchi
PRPaola Rognoni
Paola Rognoni
ESEduard Sabidó
Eduard Sabidó
MCMaria Chiara Ciuffreda
Maria Chiara Ciuffreda
FLFrancesca Lavatelli
Francesca Lavatelli
AL amyloidosis is characterized by widespread deposition of immunoglobulin light chains (LCs) as amyloid fibrils. Cardiac involvement is frequent and leads to life-threatening cardiomyopathy. Besides the tissue alteration caused by fibrils, clinical and experimental evidence indicates that cardiac damage is also caused by proteotoxicity of prefibrillar amyloidogenic species. As in other amyloidoses, the damage mechanisms at cellular level are complex and largely undefined. We have characterized the molecular changes in primary human cardiac fibroblasts (hCFs) exposedin vitroto soluble amyloidogenic cardiotoxic LCs from AL cardiomyopathy patients. To evaluate proteome alterations caused by a representative cardiotropic LC, we combined gel-based with label-free shotgun analysis and performed bioinformatics and data validation studies. To assess the generalizability of our results we explored the effects of multiple LCs on hCF viability and on levels of a subset of cellular proteins. Our results indicate that exposure of hCFs to cardiotropic LCs translates into proteome remodeling, associated with apoptosis activation and oxidative stress. The proteome alterations affect proteins involved in cytoskeletal organization, protein synthesis and quality control, mitochondrial activity and metabolism, signal transduction and molecular trafficking. These results support and expand the concept that soluble amyloidogenic cardiotropic LCs exert toxic effects on cardiac cells.

1 August 2014 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
Harold MeijerHarold Meijer
Harold Meijer
Francesco Mattia MancusoFrancesco Mattia Mancuso
Francesco Mattia Mancuso
GEGuadalupe Espadas
Guadalupe Espadas
MSMichael F. Seidl
Michael F. Seidl
CCCristina Chiva
Cristina Chiva
ESEduard Sabidó
Eduard Sabidó
Oomycetes are filamentous organisms that cause notorious diseases, several of which have a high economic impact. Well known is Phytophthora infestans, the causal agent of potato late blight. Previously, in silico analyses of the genome and transcriptome of P. infestans resulted in the annotation of a large number of genes encoding proteins with an N-terminal signal peptide. This set is collectively referred to as the secretome and comprises proteins involved in, for example, cell wall growth and modification, proteolytic processes, and the promotion of successful invasion of plant cells. So far, proteomic profiling in oomycetes was primarily focused on subcellular, intracellular or cell wall fractions; the extracellular proteome has not been studied systematically. Here we present the first comprehensive characterization of the in vivo secretome and extracellular proteome of P. infestans. We have used mass spectrometry to analyze P. infestans proteins present in seven different growth media with mycelial cultures and this resulted in the consistent identification of over two hundred proteins. Gene ontology classification pinpointed proteins involved in cell wall modifications, pathogenesis, defense responses, and proteolytic processes. Moreover, we found members of the RXLR and CRN effector families as well as several proteins lacking an obvious signal peptide. The latter were confirmed to be bona fide extracellular proteins and this suggests that, similar to other organisms, oomycetes exploit non-conventional secretion mechanisms to transfer certain proteins to the extracellular environment.